NAYLA MANSOOR: Open Payments
NPI 1225590375 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 21 payments from 14 companies in 2025. Trend: 2023 $920 · 2024 $2,473 · 2025 $1,601
Food & beverage: $1,601
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $304 |
| Arcutis Biotherapeutics, Inc. | 2 | $260 |
| Regeneron Healthcare Solutions, Inc. | 2 | $255 |
| UCB, Inc. | 2 | $250 |
| ABBVIE INC. | 2 | $146 |
| Janssen Biotech, Inc. | 1 | $111 |
| Organon LLC | 1 | $99 |
| Lilly USA, LLC | 2 | $30 |
| Novo Nordisk Inc | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
Products named: Opzelura, DUPIXENT, Bimzelx, RINVOQ, TREMFYA, VTAMA, Wegovy, COSENTYX.
Industry payments across AZ — which companies pay providers there.
